Free weekly newsletter

Get the free weekly contract digest

The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New new contracts, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Contract Trends

See who's moving and how much in your market

No credit card required Weekly contract digest

Novartis and PTC Collaborate on Up-to-$2.9B Huntington’s Disease Partnership

Dec 02, 2024•over 1 year ago

Contract Type

partnership

SwitzerlandBiotechnologyHealth Carepharmaceuticals

Description

Novartis and PTC have formed a collaboration to advance treatments for Huntington’s disease. The partnership involves a potential value of up to $2.9B.

Company Information

Company

Novartis

Location

2 Fabrikstrasse

Switzerland

About

Novartis is a global healthcare company based in Switzerland. It is focused on developing innovative medicines to improve and extend people's lives. The company operates in various therapeutic areas, including oncology, cardiology, and immunology. Novartis is known for its commitment to research and development.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Novartis's next move

Learn about Strategic plan

Agreement Insights

Based on industry data

Strategic partnership established

Partnership agreements typically involve technology integration and joint go-to-market strategies

Contract momentum indicator

Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months